Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ANDRIOLE, Gerald L")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 93

  • Page / 4
Export

Selection :

  • and

Overview of Pivotal Studies for Prostate Cancer Risk Reduction, Past and PresentANDRIOLE, Gerald L.Urology (Ridgewood, NJ). 2009, Vol 73, Num 5A, pp 36-43, issn 0090-4295, 8 p., SUPArticle

Prostate Cancer Risk: Overview of the Disease, Predictive Factors, and Potential Targets for Risk ReductionANDRIOLE, Gerald L.Urology (Ridgewood, NJ). 2009, Vol 73, Num 5A, issn 0090-4295, 45 p., SUPSerial Issue

Cost-Effectiveness of Prostate Specific Antigen Screening in the United States: Extrapolating From the European Study of Screening for Prostate CancerSHTEYNSHLYUGER, Alex; ANDRIOLE, Gerald L.The Journal of urology. 2011, Vol 185, Num 3, pp 828-832, issn 0022-5347, 5 p.Article

Safety and tolerability of the dual 5α-reductase inhibitor dutasteride in thetreatment of benign prostatic hyperplasiaANDRIOLE, Gerald L; KIRBY, Roger.European urology. 2003, Vol 44, Num 1, pp 82-88, issn 0302-2838, 7 p.Article

Prostate cancer chemoprevention with 5α-reductase inhibitorsNEPPLE, Kenneth G; ANDRIOLE, Gerald L.Urologic oncology. 2012, Vol 30, Num 5, pp 553-554, issn 1078-1439, 2 p.Article

Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5α-reductase inhibitor dutasterideANDRIOLE, Gerald L; MARBERGERT, Michael; ROEHRBORN, Claus G et al.The Journal of urology. 2006, Vol 175, Num 5, pp 1657-1662, issn 0022-5347, 6 p.Article

Prostate-Specific Antigen-Based Risk Assessment in Younger MenSTROPE, Seth A; ANDRIOLE, Gerald L.European urology. 2012, Vol 61, Num 1, pp 8-10, issn 0302-2838, 3 p.Article

Critical Appraisal of Prostate-specific Antigen in Prostate Cancer Screening: 20 Years LaterPIENTA, Kenneth J.Urology (Ridgewood, NJ). 2009, Vol 73, Num 5A, pp 11-20, issn 0090-4295, 10 p., SUPArticle

Risk of Developing Prostate Cancer in the Future: Overview of Prognostic BiomarkersFLESHNER, Neil E; LAWRENTSCHUK, Nathan.Urology (Ridgewood, NJ). 2009, Vol 73, Num 5A, pp 21-27, issn 0090-4295, 7 p., SUPArticle

Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate CancerCRAWFORD, E. David.Urology (Ridgewood, NJ). 2009, Vol 73, Num 5A, pp 4-10, issn 0090-4295, 7 p., SUPArticle

Prevention of benign prostatic hyperplasia diseaseMARKS, Leonard S; ROEHRBORN, Claus G; ANDRIOLE, Gerald L et al.The Journal of urology. 2006, Vol 176, Num 4, pp 1299-1306, issn 0022-5347, 8 p., 1Article

Application of a fixed retractor system to facilitate laparoscopic radical prostatectomyLANDMAN, Jaime; VENKATESH, Ramakrishna; VANLANGENDONCK, Richard et al.The Journal of urology. 2004, Vol 171, Num 2, pp 783-785, issn 0022-5347, 3 p., 1Article

Defining Increased Future Risk for Prostate Cancer : Evidence From a Population Based Screening Cohort. CommentarySCHRODER, Fritz H; ROOBOL, Monique J; ANDRIOLE, Gerald L et al.The Journal of urology. 2009, Vol 181, Num 1, pp 69-74, issn 0022-5347, 6 p.Article

Patterns of multiple recurrences of superficial (Ta/T1) transitional cell carcinoma of bladder and effects of clinicopathologic and biochemical factorsYAN YAN; ANDRIOLE, Gerald L; HUMPHREY, Peter A et al.Cancer. 2002, Vol 95, Num 6, pp 1239-1246, issn 0008-543XArticle

The Overlap and Distinction of Self-Reported Symptoms between Interstitial Cystitis/Bladder Pain Syndrome and Overactive Bladder: A Questionnaire Based AnalysisLAI, H. Henry; VETTER, Joel; JAIN, Sanjay et al.The Journal of urology. 2014, Vol 192, Num 6, pp 1679-1685, issn 0022-5347, 7 p.Article

Effect of Dutasteride on Prostate Biopsy Rates and the Diagnosis of Prostate Cancer in Men with Lower Urinary Tract Symptoms and Enlarged Prostates in the Combination of Avodart and Tamsulosin TrialROEHRBORN, Claus G; ANDRIOLE, Gerald L; WILSON, Timothy H et al.European urology. 2011, Vol 59, Num 2, pp 244-249, issn 0302-2838, 6 p.Article

Dutasteride improves objective and subjective disease measures in men with benign prostatic hyperplasia and modest or severe prostate enlargement. CommentaryGITTELMAN, Marc; RAMSDELL, Joe; YOUNGT, Jay et al.The Journal of urology. 2006, Vol 176, Num 3, pp 1045-1050, issn 0022-5347, 6 p.Article

Preoperative oral rofecoxib does not decrease postoperative pain or morphine consumption in patients after radical prostatectomy: A Prospective, randomized, double-blinded, placebo-controlled trialJEFFREY JIANHONG HUANG; TAGUCHI, Akiko; HSU, Hawpeng et al.Journal of clinical anesthesia. 2001, Vol 13, Num 2, pp 94-97, issn 0952-8180Article

Overdiagnosis of Prostate CancerSANDHU, Gurdarshan S; ANDRIOLE, Gerald L.Journal of the National Cancer Institute. Monographs. 2012, Vol 45, pp 146-151, issn 1052-6773, 6 p.Conference Paper

Reduction in the Risk of Prostate Cancer: Future Directions After the Prostate Cancer Prevention Trial. CommentaryCRAWFORD, E. David; ANDRIOLE, Gerald L; MARBERGER, Michael et al.Urology (Ridgewood, NJ). 2010, Vol 75, Num 3, pp 502-510, issn 0090-4295, 9 p.Article

Current Prostate Cancer Treatments: Effect on Quality of LifeGOMELLA, Leonard G; JOHANNES, James; TRABULSI, Edouard J et al.Urology (Ridgewood, NJ). 2009, Vol 73, Num 5A, pp 28-35, issn 0090-4295, 8 p., SUPArticle

Alcohol Intake Increases High-grade Prostate Cancer Risk Among Men Taking Dutasteride in the REDUCE TrialFOWKE, Jay H; HOWARD, Lauren; ANDRIOLE, Gerald L et al.European urology. 2014, Vol 66, Num 6, pp 1133-1138, issn 0302-2838, 6 p.Article

Relating biopsy and clinical variables to radical prostatectomy findings: Can insignificant and advanced prostate cancer be predicted in a screening population?ANAST, Jason W; ANDRIOLE, Gerald L; BISMAR, Tarek A et al.Urology (Ridgewood, NJ). 2004, Vol 64, Num 3, pp 544-550, issn 0090-4295, 7 p.Article

Modeling and Analysis of Gleason Score 8-10 Prostate Cancers in the REDUCE StudyANDRIOLE, Gerald L; BOSTWICK, David G; CASTRO, Ramiro et al.Urology (Ridgewood, NJ). 2014, Vol 84, Num 2, pp 393-399, issn 0090-4295, 7 p.Article

The utility of prostate-specific antigen in the management of advanced prostate cancerCRAWFORD, E. David; BENNETT, Charles L; ANDRIOLE, Gerald L et al.BJU international (Papier). 2013, Vol 112, Num 5, pp 548-560, issn 1464-4096, 13 p.Article

  • Page / 4